Fig. 1From: Oncogenic alterations in advanced NSCLC: a molecular super-highwayIncidence of oncogenic driver alterations in advanced non-small-cell lung adenocarcinoma. RET: rearranged during transfection, ERBB2: human epidermal growth factor receptor 2, BRAF: B-raf murine sarcoma viral homolog B, ROS1: ROS proto-oncogene 1, MET: c-Met, amp: amplification, ALK: anaplastic lymphoma kinase, EGFR: epidermal growth factor receptor, KRAS: Kirsten rat sarcomaBack to article page